Allworth Financial LP Agenus Inc Transaction History

Allworth Financial LP

  • $16.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023
SELL
$1.45 - $2.95 $410 - $834
-283 Reduced 61.79%
175 $0
Q4 2022

Jan 13, 2023
SELL
$2.02 - $3.25 $331 - $533
-164 Reduced 26.37%
458 $0
Q3 2022

Oct 18, 2022
BUY
$1.96 - $3.14 $876 - $1,403
447 Added 255.43%
622 $1,000
Q3 2021

Nov 02, 2021
BUY
$4.98 - $6.63 $871 - $1,160
175 New
175 $1,000

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email